// App-Quantinova.ai

: Plasma protein profiles as markers of asthma severity and exposure to oral corticosteroids in U-BIOPRED and BIOAIR

Researchers

Presenter

  • Maria Mikus

Principal Investigators

  • Johan Kolmert

  • Anna James

  • Lars I Andersson

  • Jörgen Östling

  • Cristina Gomez

  • Richard Knowles

  • Barbro Dahlén

  • Ratko Djukanovic

  • Ian M Adcock

  • Peter Nilsson

  • Sven-Erik Dahlén

Medical Centers

  • Karolinska Institutet, and KTH Royal Institute of Technology, Stockholm, Sweden

  • Karolinska Institutet, Stockholm, Sweden

  • AstraZeneca, and PEXA AB, Mölndal, Sweden

  • Knowles Consulting, Stevenage Bioscience Catalyst, Stevenage, United Kingdom

  • University of Southampton, Southampten, United Kingdom

  • Imperial College, London, United Kingdom

  • Royal Inst of Technology, Stockholm, Sweden

Locations

  • Sweden

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Autoimmune (AI)

Disease

  • Systemic inflammation

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Placebo Control

  • Multicenteric

  • Controlled

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A